NCT06595823View on ClinicalTrials.gov

Betadine Versus Saline in Swapping of Subcutaneous Tissue

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

March 5, 2023

Study Completion Date

March 10, 2023

Conditions
Surgical Site Infection
Interventions
DRUG

Betadine

To compare between Betadine (10%) and saline (0.9%) in swapping of subcutaneous tissue for prevention of surgical site infection after primary elective caesarian section.

Trial Locations (1)

71524

Al-Azhar University hospitals, Asyut

All Listed Sponsors
collaborator

Al-Azhar University

OTHER

lead

Egymedicalpedia

INDUSTRY

NCT06595823 - Betadine Versus Saline in Swapping of Subcutaneous Tissue | Biotech Hunter | Biotech Hunter